Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acceptance and Commitment Therapy in SSRI-Resistant OCD
NCT02955654Withdrawn
- Sponsor
- Shanghai Mental Health Center
- Start
- Sep 2017
- Primary completion
- Dec 2018
01
Overview
Randomised, single-blind trial in obsessive compulsive disorder (OCD) (3 arms), sponsored by Shanghai Mental Health Center. Primary endpoint: Yale-Brown Obsessive Compulsive Scale at 8 weeks. Planned start Sep 2017; status: withdrawn.
02
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT02955654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02955654.